Schonfeld Strategic Advisors LLC Alector, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $91,291 - $153,966	17,556 New	17,556 $113,000
Q3 2022 Nov 14, 2022	BUY	$8.19 - $13.2 $117,534 - $189,433	14,351 New	14,351 $136,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $363,780 - $480,152	-18,800 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$21.65 - $39.49 $110,415 - $201,399	-5,100 Reduced 21.34%	18,800 $429,000
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $370,450 - $537,272	23,900 New	23,900 $499,000

165

58.1M

57K

14.9K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $406M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.